Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,082Revenue $M205Net Margin (%)-28.1Z-Score2.3
Enterprise Value $M1,216EPS $-1.0Operating Margin %-25.4F-Score1
P/E(ttm))0Cash Flow Per Share $0.4Pre-tax Margin (%)-28.2Higher ROA y-yN
Price/Book7.210-y EBITDA Growth Rate %0Quick Ratio3.6Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %0Current Ratio4.2Lower Leverage y-yN
Price/Cash Flow35.6y-y EBITDA Growth Rate %-281.5ROA % (ttm)-15.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-37.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M42.2ROI % (ttm)-0.1Gross Margin Increase y-yN

Gurus Latest Trades with SPNC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPNCRon Baron 2014-09-30 Add0.03%$22.76 - $29.33
($27)
$ 24.33-11%Add 412.11%309,727
SPNCRon Baron 2014-06-30 Add$20.78 - $29.79
($23.2)
$ 24.335%Add 63.55%60,480
SPNCRon Baron 2014-03-31 Add$24.13 - $31.56
($27.26)
$ 24.33-12%Add 243.04%36,980
SPNCRon Baron 2013-12-31 Buy $17.2 - $25.43
($21.43)
$ 24.3312%New holding10,780
SPNCGeorge Soros 2011-09-30 Sold Out -0.0012%$5.6 - $7.62
($6.51)
$ 24.3373%Sold Out0
SPNCGeorge Soros 2011-06-30 Buy $4.68 - $6.21
($5.59)
$ 24.3377%New holding13,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPNC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SPNC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bowe Wade AVice President R&D 2015-04-02Sell15,000$34.67-24.69view
Drake Scott WilliamPresident, CEO 2015-04-02Sell20,000$34.68-24.71view
FLETCHER R JOHNDirector 2015-03-06Sell22,245$34.35-23.99view
Drake Scott WilliamPresident, CEO 2015-03-05Sell20,000$34.48-24.27view
Drake Scott WilliamPresident, CEO 2015-02-05Sell20,000$33.2-21.36view
Fuchs Robert MichaelSr. VP, Global Human Resources 2015-01-02Sell6,000$34.48-24.27view
Drake Scott WilliamPresident, CEO 2015-01-02Sell20,000$34.1-23.43view
Drake Scott WilliamPresident, CEO 2014-12-11Sell1,468$33.9-22.98view
Drake Scott WilliamPresident, CEO 2014-12-04Sell80,000$32.14-18.76view
RUGGIO JOSEPH MDirector 2014-11-03Sell5,000$31.8-17.89view

Press Releases about SPNC :

    Quarterly/Annual Reports about SPNC:

    News about SPNC:

    Articles On GuruFocus.com
    Baron Funds Comments on Spectranetics Corporation Feb 26 2014 
    Spectranetics Corp. Reports Operating Results (10-Q) Nov 08 2010 
    Spectranetics Corp. Reports Operating Results (10-Q) Nov 06 2009 
    Spectranetics Corp. Reports Operating Results (10-Q) Aug 10 2009 
    Spectranetics Corp. Reports Operating Results (10-Q) May 11 2009 
    Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19 Feb 12 2009 
    Spectranetics Cross-Pilot Product Receives FDA Clearance Dec 15 2008 
    Weekly CEO Buys Highlight: Spectranetics Corp., Noven Pharmaceuticals Inc., Dolan Media Company, Mod Sep 09 2008 

    More From Other Websites
    SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 29 2015
    Nasdaq stocks posting largest percentage decreases Apr 28 2015
    Spectranetics upgraded by Northland Capital Apr 27 2015
    Spectranetics (SPNC) Stock Slips Today on Weak Earnings Results Apr 24 2015
    Spectranetics reports 1Q loss Apr 23 2015
    Spectranetics reports 1Q loss Apr 23 2015
    Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of... Apr 23 2015
    Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million Apr 23 2015
    SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Apr 23 2015
    Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million Apr 23 2015
    Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of... Apr 23 2015
    Q1 2015 Spectranetics Corp Earnings Release - After Market Close Apr 23 2015
    Spectranetics' Stellarex(TM) Drug-coated Balloon Clinical Findings Published in Catheterization and... Apr 16 2015
    Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23 Apr 13 2015
    Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23 Apr 13 2015
    CFO Moves: Aramark, Spectranetics, Smiths Group Mar 19 2015
    SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 19 2015
    Spectranetics Announces Chief Financial Officer Transition Mar 18 2015
    Spectranetics Announces Chief Financial Officer Transition Mar 18 2015
    Spectranetics Appoints Todd C. Schermerhorn as Director Mar 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK